Sintilimab (anti-PD-1)

CAS : 2072873-06-2

Ref. TM-T35394

Informations sur le produit

• Nom: Sintilimab (anti-PD-1)
• Synonymes: IBI308, Sintilimab (anti-PD-1)
• CAS: 2072873-06-2

Description

Sintilimab (IBI308) is a humanized IgG4 monoclonal antibody with significant anti-tumor activity that restores endogenous anti-tumor T-cell responses by binding to PD-1 and thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2).Sintilimab is used in combination with other compounds for the treatment of classical Hodgkin's lymphoma, non-cellular lung cancer and esophageal cancer. Sintilimab is used in combination with other compounds to treat classical Hodgkin's lymphoma, non-small cell lung cancer and esophageal cancer.

• Marque: Targetmol

Propriétés chimiques

• Degré de pureté: 95%
• Couleur/Forme: Solid